शुभ दीपावलीDiwali offer: 3 months free on yearly plans · ends 11 NovSee plans
Companies›Healthcare›Healthcare›Healthcare Services
NSE:ONEGLOBAL

ONE GLOBAL SERVICE PROV L

Healthcare › Healthcare Services
₹363.55
at close · 6 Nov 2026
▼ 32.20 (-8.14%)

Latest filings

  1. Newspaper notice published for postal ballot and remote e-voting · Compliance
  2. Newspaper publication of September 2026 quarterly results · Compliance
  3. Postal ballot on director pay, reappointment, loan conversion and board appointment · Board & Shareholder Meetings
All filings ↓
Ask Nexa about ONE GLOBAL SERVICE PROV L

Snapshot

What the business is, and whether it's a good one at a fair price.

A Healthcare Services company listed on NSE and BSE, reporting revenue of ₹498 Cr over the trailing twelve months.

Market Cap
₹710 Cr
P / E (TTM)
10.2×
EV / EBITDA
7.5×
Div Yield
—
Growth
167.1%▲
Revenue 5y CAGR
PAT +97.2% · EBITDA +106.8%
Quality
34.4%▲
ROCE (5y median)
ROE 26.0% (5y median) · margin 18.6%
Leverage
0.00·
Debt / Equity · low
Net cash ₹16 Cr
Revenue FY21→FY26
135.9×▲
Margin −49.7 pts
₹4 Cr → ₹498 Cr
Cash conversion
0.20×▼
Operating cash ÷ profit · 5 yrs
₹19 Cr on ₹98 Cr
Where it sits among 29 Healthcare Service Provider peersBar = share of peers beaten · tick = industry median · latest reported figures
P/E (TTM)#5/25
P/B#16/24
ROCE#1/29
ROE#1/24
Debt / Equity#7/23
EBITDA margin#14/28
Revenue growth#2/25
Profit growth#6/25

Scorecard

Measured from the filed financials, judged against its Healthcare Service Provider peers · as of FY26 — not investment advice

Strengths
Revenue compounding 167% a year over 5 years
Profit compounding 97% a year over 5 years
Returns on capital 34.4% (5-year median)
#1 of 29 in Healthcare Service Provider on the latest reported figures · up from 44.8% in FY21
Debt at 0.00× equity
lower than 73% of its 23 Healthcare Service Provider peers
Concerns
Over 5 years it reported ₹98 Cr of profit and ₹19 Cr of operating cash — 0.20×
Less than 60p of every ₹1 of profit arrived as cash
EPS grew slower than profit — the share count rose (bonus or dilution)

Charts

How has the market priced it — with filings on the timeline?

ONEGLOBAL · price

Loading chart…

▲ positive · ▼ negative · ● neutral filings · teal = economic event · numbered = multiple that day (click to pick). Times IST.

Peers

How does it stack up on valuation, returns and growth?

Loading peers…

Financials

Quarterly & annual P&L, balance sheet, cash flow, ratios and segments.

Loading financials…

Ownership

Who owns it — and is the promoter stake clean?

Loading shareholding…

Sign up to see the full company file

Governance, sustainability, compliance, earnings calls, presentations, events, reactions and the full filings feed — free with an account.

Common questions

Answered from ONE GLOBAL SERVICE PROV L's filed financials and exchange disclosures

What does ONE GLOBAL SERVICE PROV L do?

ONE GLOBAL SERVICE PROV L is a Healthcare Services company listed on NSE and BSE, trading under the symbol ONEGLOBAL.

Is ONE GLOBAL SERVICE PROV L profitable?

Yes. Over the trailing twelve months ONE GLOBAL SERVICE PROV L reported a net profit of ₹69 Cr on revenue of ₹498 Cr.

Does ONE GLOBAL SERVICE PROV L pay a dividend?

Not in the latest reported year — ONE GLOBAL SERVICE PROV L's dividend payout for FY26 was nil.

Is ONE GLOBAL SERVICE PROV L debt-free?

On a net basis, yes. It reported borrowings of ₹0.03 Cr on its 31 Mar 2026 balance sheet, but holds ₹16 Cr more cash than debt.

Is ONE GLOBAL SERVICE PROV L expensive compared with its peers?

On trailing P/E, ONE GLOBAL SERVICE PROV L ranks 5 of 25 in Healthcare Service Provider — cheaper than 83% of them, against an industry median of 34.0×. This is a position, not a valuation judgement.

Where can I track ONE GLOBAL SERVICE PROV L's announcements?

Every NSE and BSE filing by ONE GLOBAL SERVICE PROV L appears on this page, AI-summarised, alongside the price reaction that followed it. Follow the company to get each new filing on WhatsApp within minutes.

Figures are as last reported and may lag the latest filing. Not investment advice.